Cervical screening update

WEBINAR: Tuesday 20 September 2022, 7.30 - 8.45 pm

In this webinar, our panel will provide an update on cervical screening, as well as information about the transition to HPV primary screening in July 2023. Topics include:

  • The importance of continuing cervical screening, now and in the future.
  • Findings from the HPV implementation research programme on women’s experiences and considerations for practice when the National Cervical Screening Programme (NCSP) transitions to HPV primary screening.
  • HPV primary screening testing options for wāhine/whānau from July 2023.
  • Demystifying colposcopy, why atrophy matters and CIN2 in the under 30s.

As always, we will answer as many questions as we can as time permits.

Presenters

John McMenamin

John is the GP/Primary Care lead for the National Screening Unit and is supporting the change management approach to transition and embed the HPV primary screening changes into the sector.  John is a Whanganui GP and is a study investigator on the University of Otago Let’s test for HPV...and prevent Cervical Cancer research project. His other roles include primary care implementation of National Bowel Screening Programme, and several national lead roles for Tobacco, Alcohol and Early Pregnancy care.

 


 

Dr Deralie Flower

Deralie works an Obstetrician and Gynaecologist at Te Toka Tumai, Auckland and is Lead Colposcopist at National Women's Health. She has worked as a colposcopist since 2008, initially in Whangārei, then returning to Tāmaki Makaurau in 2010. Deralie believes cervical screening and having a colposcopy should be an empowering journey. She teaches house officers and registrars about colposcopy and cervical screening; and incorporates a trauma-sensitive approach into her teaching and practice. She is a vocal advocate of HPV self-screening and shared decision-making in cervical screening. She is particularly excited about this next phase of the cervical screening program in Aotearoa. One of her career goals is to see colposcopy become obsolete.

 


 

Dr Karen Bartholomew

 Karen is a New Zealand Public Health Physician clinician researcher. She is involved in a number of research projects focusing on translational/implementation research in screening and health inequities. Karen leads a human papillomavirus (HPV) self-testing programme, Abdominal Aortic Aneurysm (AAA) screening research and is a co-investigator for the Māori-led Lung Cancer Screening programme Te Oranga Pūkahukahu. Karen has a Microbiology degree, is a medical doctor and has a Masters of Public Health. She also has a strong interest in public health and research ethics, and is a current member of the NZ National Screening Advisory Committee.

 


 

Jane Grant

Jane Grant is a Nurse Specialist, who has worked on three HPV self-testing trials since 2016. Jane is Clinical Lead for the current cervical screening self-testing implementation study and has recently returned from working in the HPV primary screening project team at NCSP. Jane’s background is Primary Healthcare Nursing. She has also worked in immunisation outreach and as the Cervical Screening Coordinator for Auckland and Waitematā.

 

 


 

 This webinar is supported by an educational grant from:

This presentation is intended for qualified health practitioners professional development and should not be relied upon for any other purpose. Any opinions offered are those of the presenter or other speaker and do not necessarily represent the views of Goodfellow Unit.

Sign into the website in order to register for this event.

Sign in